Structure Therapeutics (GPCR) Interest & Investment Income (2022 - 2026)

Structure Therapeutics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at -$3.2 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 133.93% year-over-year to -$3.2 million; the TTM figure through Mar 2026 stood at $40.4 million (up 26.99% YoY), while the FY2025 annual figure was $35.9 million, changed 0.39% from the prior year.
• Interest & Investment Income for Q1 2026 stood at -$3.2 million, down from $36.0 million in the prior quarter.
• The five-year high for Interest & Investment Income was $36.0 million in Q4 2025, with the low at -$3.2 million in Q1 2026.
• The 5-year median for Interest & Investment Income is $349000.0 (2022), against an average of $4.5 million.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income tumbled 974.0% in 2023, then jumped 1667.27% in 2025.
• Structure Therapeutics' Interest & Investment Income stood at $1.4 million in 2022, then plunged by 40.3% to $831000.0 in 2023, then jumped by 1189.77% to $10.7 million in 2024, then surged by 235.53% to $36.0 million in 2025, then tumbled by 109.03% to -$3.2 million in 2026.
• Business Quant data shows GPCR's Interest & Investment Income at -$3.2 million in Q1 2026, $36.0 million in Q4 2025, and $8.2 million in Q3 2025.